Dosing Challenges for Chemotherapy and Immunotherapy in Congenital Achondroplasia: a Case Report and Literature Review

Currently, no established guidelines exist for dosing chemotherapy or immunotherapy in patients with achondroplasia. A 69-year old female with congenital achondroplasia was diagnosed with stage IV non-small cell lung carcinoma type adenocarcinoma, with high Tumor Mutational Burden and 20